Efficacy of ethinylestradiol 20 µg/drospirenone 3 mg in a flexible extended regimen in women with moderate-to-severe primary dysmenorrhoea: an open-label, multicentre, randomised, controlled study

Thomas Strowitzki,Bodo Kirsch,Jörg Elliesen

doi:10.1136/jfprhc-2011-100225

Efficacy of ethinylestradiol 20 µg/drospirenone 3 mg in a flexible extended regimen in women with moderate-to-severe primary dysmenorrhoea: an open-label, multicentre, randomised, controlled study

Thomas Strowitzki, Bodo Kirsch + Show 1 more

Open Access

https://doi.org/10.1136/jfprhc-2011-100225

Copy DOI

Journal: Journal of Family Planning and Reproductive Health Care	Publication Date: Mar 27, 2012
Citations: 31	License type: open-access

Affiliation: Heidelberg University, Bayer (Germany)

#Conventional Regimen #Flexible Extended Regimen + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

ObjectivesThe aim of this Phase III, multicentre, open-label, randomised study was to compare the efficacy and safety of ethinylestradiol (EE)/drospirenone (DRSP) in a new flexible extended regimen that allowed the...

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Journal of Family Planning and Reproductive Health Care

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.